The Buck Institute’s CEO Eric Verdin on why longevity research has transformative power, but the field must tread carefully between the hype and the noise.


The Buck Institute is all about living better for longer – investigating and deciphering the biology of aging to end the threat of age-related disease. Aging is the number one risk factor for chronic disease, so the Buck deploys cutting edge science and technology and leading gerontologists in order to tackle it – but searching for immortality is definitely not something on its agenda.


The Buck Institute is headed up by Dr Eric Verdin; highly cited and with a Glenn Award for Research in Biological Mechanisms of Aging, over 210 scientific papers and more than 15 patents under his belt he is first and foremost a scientist. As longevity goes mainstream, gaining longer air time and more column inches, there is a danger that the more fringe or extreme areas of the field become the focus, rather than improving healthspan.


We sat down with Dr Verdin, President and CEO of The Buck Institute, to discuss these concerns and find out why searching for a philosopher’s stone might be good for Harry Potter but the wrong direction for geroscience.
-----------------------------------------------
Visit Longevity.Technology - https://bit.ly/3PwtH8Y


Follow Longevity.Technology on:
Twitter - https://bit.ly/3AMIXuq
Facebook - https://bit.ly/3z8H1v5
Instagram - https://bit.ly/3IDvVRX
Linkedin - https://bit.ly/3yIfDmf